Literature DB >> 6295670

Antibodies to EB virus- and cytomegalovirus-induced antigens in early rheumatoid disease.

D Male, A Young, C Pilkington, S Sutherland, I M Roitt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295670      PMCID: PMC1536684     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  11 in total

1.  Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence.

Authors:  M A Aslpaugh; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

2.  Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen.

Authors:  D Baron; J L Strominger
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

3.  Infection with E.B. virus and rheumatoid arthritis.

Authors:  C J Elson; D H Crawford; R C Bucknall; C Allen; J L Thompson; M A Epstein; N D Hall; P A Bacon
Journal:  Lancet       Date:  1979-01       Impact factor: 79.321

4.  Defective EBV-specific suppressor T-cell function in rheumatoid arthritis.

Authors:  G Tosato; A D Steinberg; R M Blaese
Journal:  N Engl J Med       Date:  1981-11-19       Impact factor: 91.245

Review 5.  Epstein-Barr virus. Its relationship to the pathogenesis of rheumatoid arthritis.

Authors:  J M Depper; N J Zvaifler
Journal:  Arthritis Rheum       Date:  1981-06

6.  Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.

Authors:  T H The; G Klein; M M Langenhuysen
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

7.  Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.

Authors:  M A Catalano; D A Carson; J C Niederman; P Feorino; J H Vaughan
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

8.  Detection of early antigens in nuclei of cells infected with cytomegalovirus or herpes simplex virus type 1 and 2 by anti-complement immunofluorescence, and use of a blocking assay to demonstrate their specificity.

Authors:  G Giraldo; E Beth; U Hämmerling; G Tarro; F M Kourilsky
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

9.  Anti-RANA antibody: a marker for seronegative and seropositive rheumatoid arthritis.

Authors:  K C Ng; K A Brown; J D Perry; E J Holborow
Journal:  Lancet       Date:  1980-03-01       Impact factor: 79.321

10.  Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis.

Authors:  M A Alspaugh; F C Jensen; H Rabin; E M Tan
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  5 in total

1.  Comparison of the immune response to Epstein-Barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  M Musiani; M Zerbini; S Ferri; M Plazzi; G Gentilomi; M La Placa
Journal:  Ann Rheum Dis       Date:  1987-11       Impact factor: 19.103

Review 2.  Role of immunity to mycobacterial stress proteins in rheumatoid arthritis.

Authors:  L McLean; V Winrow; D Blake
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

3.  Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.

Authors:  Mattias Magnusson; Mikael Brisslert; Kiandoht Zendjanchi; Magnus Lindh; Maria I Bokarewa
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

4.  Correlative studies of rheumatoid factors and anti-viral antibodies in patients with rheumatoid arthritis.

Authors:  A S Ferraro; M M Newkirk
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

5.  Anti-globulins and circulating complexes in early rheumatoid arthritis.

Authors:  F C Hay; A Young; M G Jones; L J Nineham; D K Male; I M Roitt
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.